首页|《黑热病诊疗方案(2023年版)》解读

《黑热病诊疗方案(2023年版)》解读

扫码查看
黑热病是所有寄生虫病中的第三大常见发病原因,死亡率仅次于疟疾.在亚洲地区,通过媒介的控制、诊断及治疗手段的提高,发病率在减少,但在东非地区,病例数仍在持续增加.由于疾病表现形式的千变万化,寻求新的诊断工具、开发新的治疗方法,将是未来黑热病的重点研究方向.本文对照2023年黑热病诊疗方案的重点内容进行解读,同时结合最近相关文献,以期帮助国内医疗人员更好的管理和救治黑热病患者.
Interpretation of Diagnosis and Treatment Plan for Kala-azar(2023 Edition)
Kala-azar is the third most common cause of all parasitic diseases,with a mortality rate second only to Malaria.In Asia,the incidence is decreasing through improved vector control,diagnosis and treatment,but in East Africa,the number of morbidities continues to increase.Due to the ever-changing manifestations of the disease,the search for new diagnostic tools and the development of new therapeutic methods will be the focus of research in the future.This article interpreted the key contents of Diagnosis and Treatment Plan for Kala-azar(2023 Edition)and combined them with recent relevant literature in order to help domestic medical personnel better manage and treat patients with kala-azar.

Kala-azarDiagnosis and treatmentPrevention and controlVaccine

毕红霞、刘焱斌

展开 >

四川大学华西医院感染性疾病中心,成都 610041

黑热病 诊断与治疗 防控 疫苗

2024

中国抗生素杂志
中国医药集团总公司四川抗菌素工业研究所,中国医学科学院医药生物技术研究所

中国抗生素杂志

CSTPCD北大核心
影响因子:1.08
ISSN:1001-8689
年,卷(期):2024.49(7)
  • 3